ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTR............................*XDIM350 (Ver 2.1 Jan 2001) 1100000/0 1710000/01370292A120031217EP02704280.32002013120030829EnEnEn77293820010131US85571720010516US98564620011105US20031217200351200312172003517 7A 61K 45/00 A 7A 61K 45/06 B 7A 61K 39/395 B 7A 61P 35/00 B 7A 61P 35/02 B 7A 61K 39:395 Z 7A 61K 31:70 Z // A61K39:395, A61K31:70deVERWENDUNG VON CD23 ANTAGONISTEN ZUR BEHANDLUNG VON NEOPLASTISCHEN ERKRANKUNGENenUSE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERSfrUTILISATION D'ANTAGONISTES CD23 DANS LE TRAITEMENT DES TROUBLES NEOPLASIQUESIdec Pharmaceuticals Corporation01041964304149EP/JND/CJ3030 Callan RoadSan Diego, CA 92121USHARIHARAN, Kandasamy7414 Park Village RoadSan Diego, CA 92129USHANNA, Nabil14770 Avenida InsurgentesRancho Santa Fe, CA 92067USBRASLAWSKY, Gary, R.7369 Celata LaneSan Diego, CA 92129USPATHAN, Nuzhat4715 Verada luz del SolSan Diego, CA 92129USDaniels, Jeffrey Nicholaset al00069921Page White & Farrer54 Doughty StreetLondon WC1N 2LSGBATBECHCYDEDKESFIFRGBGRIEITLILUMCNLPTSETRALLTLVMKROSIUS020262020020131EnWO0206048420020808200232